Innovation to Impact: Arvinas

May 15, 2017

Dr. Craig Crews is the Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology at Yale and the Founder and Chief Scientific Advisor of Arvinas. The company is translating innovative protein degradation approaches into novel drugs for the treatment of cancer and other diseases.

“Innovation to Impact” is a video series highlighting leading Yale entrepreneurs who have turned their groundbreaking research and innovative ideas into businesses that have raised $1M or more and are poised to have significant positive impact on human lives. “At Yale we don’t just want to make new things, we want to make things better.” — Peter Salovey, Yale President